Veraxa Biotech AG

VRXA Healthcare Biotechnology

Insiders bought in the last twelve months.

1.11 0.01 +0.91%
Market cap
$162.5M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Columns are period end dates